性结肠炎中NAD+代谢和免疫细胞透之间的相互作用:亚型识别和新型诊断模型的开发
Linglin Tian1, Huiyang Gao2, Tian Yao3,4
1Department of Gastroenterology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Frontiers in immunology
|February 20, 2025
概括
这项研究基于尼古丁胺氨酸二核酸 (NAD+) 代谢确定了两种不同的性结肠炎 (UC) 亚型. 像NNMT和PARP9这样的关键基因显示了UC的诊断潜力,为个性化治疗铺平了道路.
科学领域:
- 胃肠道学和分子生物学
- 炎症性肠道疾病研究研究
- 代谢学和基因表达分析
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症疾病,全球发病率正在上升.
- 尼古丁胺胺氨基二核酸 (NAD+) 代谢在UC病变发生过程中起着至关重要的作用.
- 研究NAD+代谢相关基因 (NMRGs) 对于了解UC亚型和诊断至关重要.
研究的目的:
- 根据NAD+代谢相关基因 (NMRGs) 将UC患者分为不同的亚型.
- 为了确定UC亚型和诊断的关键NMRG.
- 探索UC中已识别的NMRG的诊断潜力.
主要方法:
- 利用了UC患者和健康对照组的转录组数据 (GEO:GSE75214,GSE87466).
- 应用无监督聚类,GSEA,GSVA,CIBERSORT和WGCNA用于亚型和生物标志物识别.
- 使用RT-qPCR验证基因表达,并通过ROC曲线和名谱评估诊断准确性.
主要成果:
- 确定了两个UC亚型:A集群具有增强的自我修复能力和B集群具有更大的炎症.
- 发现了四个关键生物标志物 (AOX1,NAMPT,NNMT,PTGS2) 用于UC亚型和两个 (NNMT,PARP9) 用于诊断.
- 诺米图显示出高预测精度 (AUC高达0.998),NNMT和PARP9被验证为炎症结肠表皮上调.
结论:
- 建立了两个不同的基于NAD+代谢的UC亚型.
- 确定了特定的NMRG作为UC亚型和诊断的潜在生物标志物.
- 研究结果表明,UC有新的治疗目标和个性化治疗策略,旨在改善患者的治疗结果.
更多相关视频
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118
Inflammatory Bowel Disease I: Ulcerative Colitis
122
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
122
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
301
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
301
